CTRI/2013/10/004077
Recruiting
未知
Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR)Mutation Status in Non-Small Cell Lung Cancer (NSCLC) in India.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Non Small Cell Lung Cancer
- Sponsor
- Roche Products India Pvt Ltd
- Enrollment
- 250
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion Criteria
- •Patients must meet the following criteria for study entry:
- •Â· Adult male or female patients of age \>\= 18years.
- •Â· Diagnosed case of NSCLC with availability of representative tumor specimen for
- •genetic analysis, from the biopsy sample.
- •Â· Written informed consent
Exclusion Criteria
- •Patients who meet the following criteria will be excluded from study:
- •Â· Patients, who in the opinion of the investigator, are unable to comply with study
- •requirements
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Epidemiological Study to Evaluate the Prevalence and Progression of Diabetic Macular Ischemia in Patients with Diabetic Retinopathy Treated with Panretinal PhotocoagulatioJPRN-UMIN000042801Boehringer Ingelheim International GmbH539
Recruiting
Not Applicable
RETROSPECTIVE OBSERVATIONAL STUDY OF BRAF AND PIK3CA MUTATION IN INDIAN PATIENTS WITH COLORECTAL CANCERâ??Health Condition 1: null- Colorectal CancerHealth Condition 2: C189- Malignant neoplasm of colon, unspecifiedCTRI/2016/06/006989Tata Memorial Hospital
Recruiting
Not Applicable
Epidemiological Study to Determine the Prevalence of ctDNA Positivity in Participants With Stage II (High Risk) or Stage III CRC After Surgery With Curative (R0) Intent and Subsequent Adjuvant Chemotherapy With Monitoring of ctDNA During Clinical Follow-upColorectal Cancer Stage IIColorectal Cancer Stage IIIDRKS00025104BioNTech SE1,500
Completed
Not Applicable
A study to find out total number of Diabetic patients and Factors influencing it in our Kanyakumari district , its severity , associated health problems and how our behavioral modifications controls the same.CTRI/2019/09/021122RojaVanam Trust256
Recruiting
Not Applicable
Prospective study for determining the prevalence of causes of ABO blood group discrepancies and to establish a clinical classification in a tertiary care transfusion centeHealth Condition 1: Z671- Type A bloodHealth Condition 2: Z673- Type AB bloodHealth Condition 3: Z672- Type B bloodHealth Condition 4: Z674- Type O bloodCTRI/2023/06/053798MAHE Thesis Grant